מכפיל P/S עתידי Ascentage Pharma Group (AAPG)
The forward P/S multiple for Ascentage Pharma Group (AAPG) reflects the impact of geopolitical tensions between Beijing and Washington on share prices, with the current value standing at 8.50. Environmental responsibility regarding chemical disposal is coupled with serious challenges: prolonged waiting periods for regulatory verdicts and significant costs associated with the final stages of clinical drug trials.
פילוחים אנליטיים של חברת Ascentage Pharma Corp (AAPG)
High uncertainty regarding the clinical trial outcomes of Ascentage Pharma Group (AAPG) anti-tumor drugs directly impacts market expectations for future sales. By analyzing the forward price-to-sales valuation trend, an investor can observe the ratio of current market capitalization to projected revenue, which determines the extent to which the cost of capital is inflated relative to the risks of commercial failure within the competitive oncology segment.
